Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational Study

Recruiting now

Conditions studied: Breast Cancer, Liver Metastases

In brief

The liver represents the third most common site of breast cancer (BC) metastases behind the lymphatics and bone. The primary treatment for BCLM remains chemo-therapy and, more recently, targeted immunotherapy. The role of liver resection in BCLM remains controversial. The primary aim of the study is to compare the efficacy of liver resection vs. medical therapy alone in Breast Cancer Liver Metastasis (BCLM) patients.

Key facts

Study ID

NCT06093022

Run by

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

People needed

720

Starts

2018-04-01

Expected to finish

2028-12-31

Last updated by the study team

2023-11-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• > 18 years old
• BCLM
• BCLM and extra-hepatic disease
• Any treatment
• Ability to understand and sign the informed consent

You may not qualify if…

• Inability to provide the informed consent
• Patient who underwent Best Supportive Care or Palliation

Where it is running

• Fondazione Policlinico Universitario Agostino Gemelli IRCCS — Rome, Lazio, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.